Huadong Medicine Co Ltd (000963) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Huadong Medicine Co Ltd (000963) has a cash flow conversion efficiency ratio of 0.006x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥155.98 Million ≈ $22.82 Million USD) by net assets (CN¥24.50 Billion ≈ $3.58 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 000963 net asset quality index to measure how much of total assets are equity-financed.
Huadong Medicine Co Ltd - Cash Flow Conversion Efficiency Trend (1998–2024)
This chart illustrates how Huadong Medicine Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Huadong Medicine Co Ltd (000963) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Huadong Medicine Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Huadong Medicine Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Vietnam Prosperity Joint Stock Commercial Bank
VN:VPB
|
0.065x |
|
Merlin Properties SOCIMI SA
MC:MRL
|
0.008x |
|
Advanced Fiber Resources Zhuhai Ltd
SHE:300620
|
0.075x |
|
Alkermes Plc
NASDAQ:ALKS
|
-0.095x |
|
Pearson plc
F:PESA
|
0.054x |
|
Shanghai Putailai New Energy Technology Co.Ltd.
SHG:603659
|
0.046x |
|
Telekom Malaysia Bhd
KLSE:4863
|
0.023x |
|
Svenska Cellulosa Aktiebolaget SCA (publ)
ST:SCA-B
|
0.010x |
Annual Cash Flow Conversion Efficiency for Huadong Medicine Co Ltd (1998–2024)
The table below shows the annual cash flow conversion efficiency of Huadong Medicine Co Ltd from 1998 to 2024. For the full company profile with market capitalisation and key ratios, see Huadong Medicine Co Ltd market cap and net worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥23.56 Billion ≈ $3.45 Billion |
CN¥3.75 Billion ≈ $548.59 Million |
0.159x | -12.61% |
| 2023-12-31 | CN¥21.58 Billion ≈ $3.16 Billion |
CN¥3.93 Billion ≈ $574.97 Million |
0.182x | +46.58% |
| 2022-12-31 | CN¥19.18 Billion ≈ $2.81 Billion |
CN¥2.38 Billion ≈ $348.54 Million |
0.124x | -33.62% |
| 2021-12-31 | CN¥16.94 Billion ≈ $2.48 Billion |
CN¥3.17 Billion ≈ $463.84 Million |
0.187x | -16.75% |
| 2020-12-31 | CN¥15.18 Billion ≈ $2.22 Billion |
CN¥3.41 Billion ≈ $499.20 Million |
0.225x | +44.46% |
| 2019-12-31 | CN¥12.87 Billion ≈ $1.88 Billion |
CN¥2.00 Billion ≈ $292.91 Million |
0.156x | -20.47% |
| 2018-12-31 | CN¥10.43 Billion ≈ $1.53 Billion |
CN¥2.04 Billion ≈ $298.44 Million |
0.196x | +3.74% |
| 2017-12-31 | CN¥8.81 Billion ≈ $1.29 Billion |
CN¥1.66 Billion ≈ $243.07 Million |
0.189x | +6.99% |
| 2016-12-31 | CN¥7.64 Billion ≈ $1.12 Billion |
CN¥1.35 Billion ≈ $197.10 Million |
0.176x | -13.19% |
| 2015-12-31 | CN¥3.24 Billion ≈ $474.60 Million |
CN¥658.54 Million ≈ $96.36 Million |
0.203x | -30.97% |
| 2014-12-31 | CN¥2.52 Billion ≈ $368.56 Million |
CN¥740.85 Million ≈ $108.41 Million |
0.294x | +85.94% |
| 2013-12-31 | CN¥3.02 Billion ≈ $441.21 Million |
CN¥476.98 Million ≈ $69.80 Million |
0.158x | -42.36% |
| 2012-12-31 | CN¥2.34 Billion ≈ $342.72 Million |
CN¥642.73 Million ≈ $94.05 Million |
0.274x | +2954.34% |
| 2011-12-31 | CN¥1.79 Billion ≈ $262.60 Million |
CN¥16.12 Million ≈ $2.36 Million |
0.009x | +143.20% |
| 2010-12-31 | CN¥1.35 Billion ≈ $196.94 Million |
CN¥-27.99 Million ≈ $-4.10 Million |
-0.021x | -104.74% |
| 2009-12-31 | CN¥1.29 Billion ≈ $189.31 Million |
CN¥567.94 Million ≈ $83.11 Million |
0.439x | +13.71% |
| 2008-12-31 | CN¥892.80 Million ≈ $130.64 Million |
CN¥344.69 Million ≈ $50.44 Million |
0.386x | -0.61% |
| 2007-12-31 | CN¥684.27 Million ≈ $100.13 Million |
CN¥265.79 Million ≈ $38.89 Million |
0.388x | +393.01% |
| 2006-12-31 | CN¥728.30 Million ≈ $106.57 Million |
CN¥57.38 Million ≈ $8.40 Million |
0.079x | -73.38% |
| 2005-12-31 | CN¥686.99 Million ≈ $100.53 Million |
CN¥203.33 Million ≈ $29.75 Million |
0.296x | +1435.72% |
| 2004-12-31 | CN¥648.91 Million ≈ $94.96 Million |
CN¥12.51 Million ≈ $1.83 Million |
0.019x | -86.42% |
| 2003-12-31 | CN¥637.95 Million ≈ $93.35 Million |
CN¥90.54 Million ≈ $13.25 Million |
0.142x | +260.25% |
| 2002-12-31 | CN¥607.81 Million ≈ $88.94 Million |
CN¥23.94 Million ≈ $3.50 Million |
0.039x | -79.24% |
| 2001-12-31 | CN¥578.05 Million ≈ $84.59 Million |
CN¥109.67 Million ≈ $16.05 Million |
0.190x | +400.09% |
| 2000-12-31 | CN¥516.34 Million ≈ $75.56 Million |
CN¥19.59 Million ≈ $2.87 Million |
0.038x | -66.12% |
| 1999-12-31 | CN¥502.91 Million ≈ $73.59 Million |
CN¥56.32 Million ≈ $8.24 Million |
0.112x | +5.70% |
| 1998-12-31 | CN¥224.63 Million ≈ $32.87 Million |
CN¥23.80 Million ≈ $3.48 Million |
0.106x | -- |
About Huadong Medicine Co Ltd
Huadong Medicine Co., Ltd, together with its subsidiaries, engages in the wholesale and retail of pharmaceutical products in China and internationally. It operates through Pharmaceutical Industry, Pharmaceutical Business, Aesthetic Medicine, and Industrial Microbiology segments. The company distributes Chinese and western medicines, Chinese herbal medicines, and medical instruments; and immunosup… Read more